Compare ESI & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESI | ELAN |
|---|---|---|
| Founded | 1922 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 10.3B |
| IPO Year | 2014 | 2018 |
| Metric | ESI | ELAN |
|---|---|---|
| Price | $35.04 | $26.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $33.70 | $27.63 |
| AVG Volume (30 Days) | 2.9M | ★ 4.1M |
| Earning Date | 05-20-2026 | 05-25-2026 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | $2,551,200,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $11.12 | $6.83 |
| Revenue Next Year | $6.38 | $5.26 |
| P/E Ratio | $45.10 | ★ N/A |
| Revenue Growth | 3.84 | ★ 6.22 |
| 52 Week Low | $16.77 | $8.02 |
| 52 Week High | $37.14 | $27.72 |
| Indicator | ESI | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 65.26 | 61.77 |
| Support Level | $24.14 | $20.73 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.40 | 0.90 |
| MACD | 0.19 | 0.10 |
| Stochastic Oscillator | 71.56 | 67.30 |
Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company's reportable segments are Electronics and Industrial & Specialty. The Electronics segment, which generates maximum revenue, researches, formulates, and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging. This segment's wet chemicals for metallization, surface treatments, and solderable finishes form the physical circuitry pathways, and its assembly materials, such as solder, pastes, fluxes, and adhesives, join those pathways together.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.